Accelerate to discover

Back to filter

Related topics

COVID‐19: Flow cytometry supporting the new challenge for global health

Cytek Biosciences

Apr 9, 2020

Several studies have described the biological and immunological features of the previous coronavirus epidemics, and...

Low-dose imaging in preclinical total-body PET/CT scanner

Bruker Biospin

Apr 8, 2020

Ionizing radiation constitutes a health risk to imaging scientists and study animals. Both PET and CT produce ionizing...

Centrifugation less sample prep. to push forward COVID-19 vaccines development

Curiox

Apr 6, 2020

Sample prep involving centrifugation is risky with potentially infectious samples. Centrifugation of samples can lead...

Loss of Notch1 activity inhibits prostate cancer growth

Spectral Instruments Imaging

Apr 1, 2020

 Prostate cancer remains among the leading causes of cancer-related deaths in men. Loss of NOTCH1 in aggressive...

Apr 9, 2020

xCELLigence system: rapid and sensitive, ideal for infectious viral assays.

Acea Biosciences

Mar 30, 2020

As the public health threat from COVID-19 and future emergent viruses continue to persist, the rapid, sensitive, and...

Genotype-targeted local therapy of glioma

Spectral Instruments Imaging

Mar 26, 2020

Lower-grade gliomas are often characterized by mutations in metabolism-related genes isocitrate dehydrogenase 1 (IDH1)...

Cytek spectral cytometers: 21 color panels with just 2 lasers

Cytek Biosciences

Mar 23, 2020

Until recently, developing multicolor fluorescence-based flow cytometry assays on a two laser system has been limited...

Apr 9, 2020

Cancer cells resist mechanical destruction in the circulation via RhoA-myosin II axis

Spectral Instruments Imaging

Mar 20, 2020

Tumors may generate millions of Circulating tumor cells per day, but seminal work in cancer biology has established the...

Show all topics (10)

δT cells and CD8+ T cells targeting of breast cancer cells

Jul 11, 2018

Cancer stem cells (CSCs) are a very rare type of cells which causes metastasis in breast cancer. Their resistance to existing therapies makes effective treatment of breast cancer in later stages very difficult. Here researchers from Cardiff University did a study on their relationship with δT cells and CD8+ T cells to help develop new treatments.
The CSCs are developed with epithelial-to-mesenchymal transition (EMT) and judged based on the CD44 hi/lo phenotype. With these cells, an immunotherapy treatment can be tested with expanded or genetically engineered T cells.

The researchers have found a synergism between γδT cells and CD8+T cells in the eradication of CSCs cells. This suggests that an approach with the combination of MHC-restricted and non-MHC-restricted may be beneficial for breast cancer patients. The paper also offers an interesting and useful tool to study CSC cells.

Scientific paper
Application

Related technologies: Live cell imaging

Brand profile

Etaluma

With a focus on portability, ease of use, high-quality imaging and fast frame-rate, Etaluma developed new concept in simple, affordable, and accessible fluorescence microscopy.

Related products

The true color inverted brightfield microscopy with all of the LumaView software features of the fluorescent LumaScope

show detail

The original single color 488nm excitation fluorescence inverted microscopy

show detail

Lumascope 620 offers a larger sensor and 3-color fluorescence for the most powerful microscope offered anywhere at this price

show detail

Blue, green & red fluorescence and walk-away automation

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey